Swiss nutra and pharma ingredient player Bioseutica has sold 85% of its KD Pharma high-end omega-3 business to German equity firm Capiton. Serious expansion is planned.
US microalgal oils firm BioProcess Algae has struck a deal with KD-Pharma - the German fats and oils division of Swiss firm Bioseutica - to supply it with ultra-concentrated EPA-rich omega-3 oils for nutraceutical and pharma applications.